Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bristol/Merck Receive Pargluva "Approvable" Letter

Oct 18 2005

• By Andrew Shelton

Related Content

Bristol/Merck's Pargluva Combination Use With Sulfonylureas Not Recommended

Sep 09 2005

Pargluva Fluid Retention, Cardiac Risk To Be Central Issues At Advisory Committee

Sep 08 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window